FR2306993B1 - - Google Patents
Info
- Publication number
- FR2306993B1 FR2306993B1 FR7609360A FR7609360A FR2306993B1 FR 2306993 B1 FR2306993 B1 FR 2306993B1 FR 7609360 A FR7609360 A FR 7609360A FR 7609360 A FR7609360 A FR 7609360A FR 2306993 B1 FR2306993 B1 FR 2306993B1
- Authority
- FR
- France
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/567,224 US4029655A (en) | 1975-04-11 | 1975-04-11 | Method of preparing stable sterile crystalline cephalosporins for parenteral administration |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2306993A1 FR2306993A1 (fr) | 1976-11-05 |
| FR2306993B1 true FR2306993B1 (enExample) | 1978-11-17 |
Family
ID=24266257
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR7609360A Granted FR2306993A1 (fr) | 1975-04-11 | 1976-03-31 | Procede de preparation de cephalosporines cristallines, steriles et stables pour administration parenterale |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US4029655A (enExample) |
| JP (1) | JPS51123813A (enExample) |
| BE (1) | BE840280A (enExample) |
| CA (1) | CA1068680A (enExample) |
| DE (1) | DE2614668C2 (enExample) |
| ES (1) | ES446906A1 (enExample) |
| FR (1) | FR2306993A1 (enExample) |
| GB (1) | GB1537874A (enExample) |
| IE (1) | IE42955B1 (enExample) |
| IL (1) | IL49073A (enExample) |
| NL (1) | NL7603659A (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3996355A (en) * | 1975-01-02 | 1976-12-07 | American Home Products Corporation | Permanent suspension pharmaceutical dosage form |
| IL53427A0 (en) * | 1976-11-24 | 1978-01-31 | Lilly Co Eli | Method of preparing a rapidly dissolving powder of sterile crystalline cefozolin sodium for parenteral administration |
| US4115644A (en) * | 1977-09-19 | 1978-09-19 | Eli Lilly And Company | Process for preparing pure cefamandole from alkali metal and ammonium salts thereof |
| US4132848A (en) * | 1977-11-03 | 1979-01-02 | Eli Lilly And Company | Method of preparing a rapidly dissolving powder of crystalline cephalothin sodium for parenteral administration |
| FR2421905A1 (fr) * | 1977-11-24 | 1979-11-02 | Lilly Co Eli | Preparation d'une poudre de cephalothine-sodiu m stable, pour administration parenterale |
| JPS54147917A (en) * | 1978-05-08 | 1979-11-19 | Sumitomo Chem Co Ltd | Ferrze-drying method |
| YU44680B (en) * | 1982-07-30 | 1990-12-31 | Glaxo Lab Ltd | Process for obtaining very pure amorphous form of cephuroxim axetile |
| JPS60120886A (ja) * | 1983-12-02 | 1985-06-28 | Takeda Chem Ind Ltd | セフェムカルボン酸のナトリウム塩の結晶 |
| JPH06786B2 (ja) * | 1984-02-22 | 1994-01-05 | 塩野義製薬株式会社 | セフアロチンナトリウムの結晶性凍結乾燥製剤の製造法 |
| US4910301A (en) * | 1985-08-05 | 1990-03-20 | Bristol-Myers Company | Cefepime cephalosporin salts |
| US5244891A (en) * | 1985-08-05 | 1993-09-14 | Bristol-Myers Squibb Company | Injectable compositions of cefepime dihydrochloride hydrate |
| US4714760A (en) * | 1985-08-20 | 1987-12-22 | Bristol-Myers Company | Cephalosporin intermediates |
| US4808617A (en) * | 1985-12-18 | 1989-02-28 | Bristol-Myers Company | Lyophilized or precipitated cephalosporin zwitterion and salt combination |
| GB8808433D0 (en) * | 1988-04-11 | 1988-05-11 | Merck Sharp & Dohme | Therapeutic agents |
| TW264475B (enExample) * | 1991-09-20 | 1995-12-01 | Takeda Pharm Industry Co Ltd | |
| US6111098A (en) * | 1994-05-02 | 2000-08-29 | Shionogi & Co., Ltd. | Crystal of pyrrolidylthiocarbapenem derivative, lyophilized preparation containing said crystal, and process for producing the same |
| DE602005002742T2 (de) * | 2004-04-22 | 2008-01-24 | Pfizer Products Inc., Groton | Verfahren zur stabilisierung von ungeordnetem cefovecin-natriumsalz |
| CN101759708B (zh) * | 2008-12-23 | 2012-07-04 | 深圳信立泰药业股份有限公司 | 头孢地嗪钠晶型及其制备方法和含有该晶型的药物组合物 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3085884A (en) * | 1958-07-28 | 1963-04-16 | Liquefreeze Company Inc | Method of freezing and shipping foodstuffs |
| GB1234802A (en) * | 1968-04-19 | 1971-06-09 | British American Tobacco Co | Improvements relating to the packing of liquids |
| US3725003A (en) * | 1969-11-04 | 1973-04-03 | Moore Perk Corp | Method of sterile packaging |
-
1975
- 1975-04-11 US US05/567,224 patent/US4029655A/en not_active Expired - Lifetime
-
1976
- 1976-02-18 IE IE316/76A patent/IE42955B1/en unknown
- 1976-02-19 IL IL49073A patent/IL49073A/xx unknown
- 1976-02-20 CA CA246,175A patent/CA1068680A/en not_active Expired
- 1976-03-31 FR FR7609360A patent/FR2306993A1/fr active Granted
- 1976-04-01 JP JP51036674A patent/JPS51123813A/ja active Granted
- 1976-04-01 BE BE1007297A patent/BE840280A/xx not_active IP Right Cessation
- 1976-04-05 DE DE2614668A patent/DE2614668C2/de not_active Expired
- 1976-04-07 NL NL7603659A patent/NL7603659A/xx not_active Application Discontinuation
- 1976-04-07 GB GB14019/76A patent/GB1537874A/en not_active Expired
- 1976-04-10 ES ES446906A patent/ES446906A1/es not_active Expired
-
1977
- 1977-02-09 US US05/767,234 patent/US4104391A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| CA1068680A (en) | 1979-12-25 |
| IL49073A (en) | 1979-03-12 |
| BE840280A (fr) | 1976-10-01 |
| DE2614668C2 (de) | 1986-10-30 |
| DE2614668A1 (de) | 1976-10-21 |
| US4104391A (en) | 1978-08-01 |
| IL49073A0 (en) | 1976-04-30 |
| JPS6143356B2 (enExample) | 1986-09-26 |
| NL7603659A (nl) | 1976-10-13 |
| JPS51123813A (en) | 1976-10-28 |
| GB1537874A (en) | 1979-01-04 |
| IE42955L (en) | 1976-10-11 |
| FR2306993A1 (fr) | 1976-11-05 |
| US4029655A (en) | 1977-06-14 |
| ES446906A1 (es) | 1977-05-16 |
| IE42955B1 (en) | 1980-11-19 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |